BAP1 and cancer: Intriguingly, neurocognitive phenotypes have not been reported in patients with cancer-associated loss-of-function BAP1 variants, suggesting that neurodevelopment is altered by mechanisms other than loss of function, that other variants that influence BAP1 function are in cis or trans, or that there is variable expressivity of BAP1-associated phenotypes.